Filing Flows › Comparisons › KRRO vs JAGX
Korro Bio vs Jaguar Health: KRRO and JAGX compared
Korro Bio is the larger company: $1.3M of revenue in its latest quarter (Q4 2025) against $1.2M for Jaguar Health (Q2 2026). Korro Bio is growing faster (-43% against -59% a year earlier).
Where the money goes: KRRO and JAGX
Korro Bio (KRRO) · Q4 2025
Korro Bio, Q4 2025: revenue $1.3M (-43% year over year), net loss $50.0M, operating cash flow −$17.7M. The chart follows the revenue to costs, profit and cash.
Jaguar Health (JAGX) · Q2 2026
Jaguar Health, Q2 2026: revenue $1.2M (-59% year over year), operating margin -620.2%, net loss $12.8M, operating cash flow −$5.3M. The chart follows the revenue to costs, profit and cash.
| Korro Bio (KRRO) | Jaguar Health (JAGX) | |
|---|---|---|
| Latest quarter | Q4 2025 | Q2 2026 |
| Revenue | $1.3M | $1.2M |
| Revenue growth, Y/Y | -43% | -59% |
| Operating margin | n/m | -620.2% |
| Net earnings | −$50.0M | −$12.8M |
| Operating cash flow | −$17.7M | −$5.3M |
Where the revenue comes from
Jaguar Health
- Product: $1.2M (96%)
- License: $43K (4%)
Questions
Which is bigger, Korro Bio or Jaguar Health?
Korro Bio is the larger company: $1.3M of revenue in its latest quarter (Q4 2025) against $1.2M for Jaguar Health (Q2 2026).
Is Korro Bio or Jaguar Health growing faster?
Korro Bio is growing faster (-43% against -59% a year earlier).
More: Korro Bio earnings · how Korro Bio makes money · Jaguar Health earnings · how Jaguar Health makes money
From the companies' latest 10-Q, 10-K or earnings release (10-K filed Mar 12, 2026; 10-Q filed Aug 19, 2026). Fiscal quarters can end on different dates. Not investment advice.